K Number
K033007
Date Cleared
2003-11-14

(49 days)

Product Code
Regulation Number
862.3320
Panel
CH
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The ADVIA IMS® Digoxin method is for in vitro diagnostic use to quantitatively measure digoxin, a cardioactive drug, in human serum. Measurements obtained are used as an aid in the diagnosis of digoxin overdose and in monitoring therapeutic levels of digoxin to ensure appropriate therapy.

Device Description

Not Found

AI/ML Overview

The Bayer ADVIA IMS® Digoxin assay is intended for in vitro diagnostic use to quantitatively measure digoxin, a cardioactive drug, in human serum. This product is used as an aid in diagnosing digoxin overdose and monitoring therapeutic levels of digoxin for appropriate therapy.

Here's an analysis of the provided information regarding the acceptance criteria and the study proving the device meets these criteria:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state formal "acceptance criteria" with numerical thresholds for performance metrics. However, the study aims to demonstrate substantial equivalence to the predicate device, the Immuno 1 Digoxin Assay. Therefore, the "reported device performance" is compared directly against the predicate device's performance, implying that performance comparable to or better than the predicate is the de facto acceptance criterion.

Performance CharacteristicAcceptance Criteria (Implied: Comparable to Immuno 1)Reported Device Performance (ADVIA IMS)Predicate Device Performance (Immuno 1)
Imprecision (Total CV%)Comparable to or better than Immuno 1Level 0.75 ng/mL: 6.0%Level 0.7 ng/mL: 8.2%
Level 1.9 ng/mL: 5.9%Level 2.2 ng/mL: 4.2%
Level 3.3 ng/mL: 3.8%Level 3.4 ng/mL: 3.6%
Correlation (vs. Immuno 1)Strong correlation (R-value close to 1)Regression: Y=1.017X+0.055N/A (Immuno 1 is the comparison)
Low SyxSyx: 0.265 ng/mLN/A
R-value close to 1R: 0.985N/A
Interference (Bilirubin)% Deviation within acceptable limits (likely

§ 862.3320 Digoxin test system.

(a)
Identification. A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.(b)
Classification. Class II.